Centre of Evidence of Dermatology Best practice guidelines

Guidelines hidradenitis suppurativa Updated on august 2019


The information provided by this website comes from sources deemed reliable. However, the French Dermatology Society recommends that the user ensure the validity of this information. Some may prove to be erroneous or be subject to typos or display errors.

The use of this data is under the sole responsibility of the user. The French Dermatology Society cannot be blamed for a misinterpretation of the data provided by the site, or in the event of erroneous information. This decision tree and all the contents of this site have been developed in the context of updated data from science according to the HAS methodology, expert opinions and reviewers of the various documents and in the context of the French healthcare system.

Context and objectives of the recommendation

Back to decision-making tree Print last updated on 12/02/2020


These recommendations for the treatment of hidradenitis suppurativa (HS), also known as Verneuil disease, have been elaborated by the Centre de Preuves en Dermatologie (Centre of Evidence of Dermatology) to provide medical professionals treating patients suffering from this disease with decision-making tools. The goal is to facilitate the diagnosis and treatment of this disease, for which few factual data are available. Recommendations will be updated in the coming years, according to new scientific data.

Patients concerned by these recommendations

Adolescent or adult patients presenting with hidradenitis suppurativa.

Medical professionals concerned

The professionals concerned are medical staff treating patients suffering from hidradenitis suppurativa, in particular dermatologists, infectious disease specialists, surgeons (in particular plastic surgeons), addictologists and general practitioners, but also emergency internists, gynaecologists, gastroenterologists, rheumatologists, paediatricians, psychologists, nursing staff and dieticians who may be involved in treating this disease.

Working group

A multidisciplinary and multiprofessional working group was set up.
It is composed of the following members:

The president co-ordinated the group’s work; the project leader identified and selected elements of the rationale and co-ordinated its drafting. The drafting of the scientific rationale was based on a critical analysis and a summary of the literature (participation of all work group members).

back to decision-making tree

  • Was this article helpful to you?
  • Your opinion counts!

    This notice will not be published on this site, but only sent to the publication management. Your email will only be used to reply to you if we deem it necessary. No response will be sent to any request for medical advice via this form.

Centre of Evidence of Dermatology Centre of Evidence of Dermatology logo
10 cité Malesherbes
Work +33.1 43 27 01 56
Fax +33.1 43 27 01 86